At the Intersection of Science and Law
By DLA Piper
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by DLA Piper
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 13
Description
In DLA Piper’s At the Intersection of Science and Law podcast, members of the firm’s Life Sciences team explore the connection between science and the law in areas that include AI and drug discovery, mRNA technology, and the regulatory implications of new drugs and devices.
| Episode | Date |
|---|---|
|
Life sciences companies and the risks posed by the mifepristone litigation
|
May 19, 2023 |
|
Trade secrets protection in the life sciences sector
|
Apr 12, 2023 |
|
Cross-border considerations for privacy in clinical trials
|
Feb 06, 2023 |
|
Global Life Sciences Supply Chain Insights
|
Nov 03, 2022 |
|
AI risk assessments: Future-proofing your innovation when rules can change mid-game
|
Sep 06, 2022 |
|
The rise of global telehealth
|
Jun 01, 2022 |
|
Advising the advisor: Tips for navigating the life sciences and regulatory environment
|
Apr 18, 2022 |
|
The moral imperative: Balancing innovation, regulation and prescription drug availability
|
Mar 21, 2022 |
|
Incentivizing diverse representation in clinical trials
|
Mar 02, 2022 |
|
The crossroad of science and law
|
Dec 16, 2021 |
|
Social media’s impact on the life sciences industry
|
Nov 08, 2021 |
|
Understanding AI and its use in drug discovery
|
Oct 05, 2021 |
|
mRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando
|
Sep 03, 2021 |